[Infusion mixtures--study of clinical practice in Austria].

M Haslinger-Matzenauer, H Karger, K Kirchdorfer, L Petcold, J Rosmann van Goethem, H Kerbl, S Zadravec
{"title":"[Infusion mixtures--study of clinical practice in Austria].","authors":"M Haslinger-Matzenauer,&nbsp;H Karger,&nbsp;K Kirchdorfer,&nbsp;L Petcold,&nbsp;J Rosmann van Goethem,&nbsp;H Kerbl,&nbsp;S Zadravec","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Options in parenteral therapy increasingly require administration of several medications simultaneously. Very little is known about the compatibility and pharmacological stability of such mixtures. We investigated how widespread this practice is, which carrier solutions are most commonly used, and whether specific medication mixtures ('cocktails') or constant formulations for TPN are applied. Upon our request, physicians and nursing staff of 54 general hospital wards (19 surgical, 18 internal medicine, 17 intensive care) in 17 Austrian hospitals recorded the parenteral admixtures for one week under the supervision of a hospital pharmacist. We found that: 1. Admixing is commonly practiced in all wards. In all but one of the wards two or even more medications are added into one single infusion. 2. Carrier solutions were: Dextrose/fructose (87% of the wards), electrolytes (90%), amino acids (40%), fat emulsions (26%), colloids (14.8%), albumin (5.5%) and Solcoseryl (5.5%). 3. Fixed combinations for i.v. therapy are practiced in 70% of the wards (mostly analgetics with corticosteroids or vitamins) 4. In almost half of the units constant formulations for TPN exist (46%). Only few of the combinations named have been investigated or tested for stability. The compatibility of most of the admixtures is unknown, while a few are clearly incompatible. Admixtures to one of the carrier solutions (Solcoseryl) are known to have caused serious complications before. For several admixtures, conflicting data about compatibility were found in the literature. The theoretical basis for incompatibilities is discussed together with some typical examples. Also some rules for admixtures are given. Questions concerning the compatibility of simultaneous parenteral drug applications are too specific to be answered for most physicians. Advice and counseling on this subject should become a new task for clinical pharmacists.</p>","PeriodicalId":77545,"journal":{"name":"Infusionstherapie (Basel, Switzerland)","volume":"18 3","pages":"114-20"},"PeriodicalIF":0.0000,"publicationDate":"1991-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infusionstherapie (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Options in parenteral therapy increasingly require administration of several medications simultaneously. Very little is known about the compatibility and pharmacological stability of such mixtures. We investigated how widespread this practice is, which carrier solutions are most commonly used, and whether specific medication mixtures ('cocktails') or constant formulations for TPN are applied. Upon our request, physicians and nursing staff of 54 general hospital wards (19 surgical, 18 internal medicine, 17 intensive care) in 17 Austrian hospitals recorded the parenteral admixtures for one week under the supervision of a hospital pharmacist. We found that: 1. Admixing is commonly practiced in all wards. In all but one of the wards two or even more medications are added into one single infusion. 2. Carrier solutions were: Dextrose/fructose (87% of the wards), electrolytes (90%), amino acids (40%), fat emulsions (26%), colloids (14.8%), albumin (5.5%) and Solcoseryl (5.5%). 3. Fixed combinations for i.v. therapy are practiced in 70% of the wards (mostly analgetics with corticosteroids or vitamins) 4. In almost half of the units constant formulations for TPN exist (46%). Only few of the combinations named have been investigated or tested for stability. The compatibility of most of the admixtures is unknown, while a few are clearly incompatible. Admixtures to one of the carrier solutions (Solcoseryl) are known to have caused serious complications before. For several admixtures, conflicting data about compatibility were found in the literature. The theoretical basis for incompatibilities is discussed together with some typical examples. Also some rules for admixtures are given. Questions concerning the compatibility of simultaneous parenteral drug applications are too specific to be answered for most physicians. Advice and counseling on this subject should become a new task for clinical pharmacists.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
输液混合物——奥地利临床实践研究。
肠外治疗越来越需要同时使用几种药物。人们对这种混合物的相容性和药理学稳定性知之甚少。我们调查了这种做法有多普遍,哪种载体溶液最常用,以及是否应用了TPN的特定药物混合物(“鸡尾酒”)或恒定配方。根据我们的要求,奥地利17家医院的54个综合医院病房(19个外科病房,18个内科病房,17个重症监护病房)的医生和护理人员在医院药剂师的监督下记录了一周的非肠外混合物。我们发现:1。混合在所有病房都很常见。除了一个病房外,其他所有病房都在一次输注中加入了两种甚至更多的药物。2. 载体溶液为:葡萄糖/果糖(87%)、电解质(90%)、氨基酸(40%)、脂肪乳(26%)、胶体(14.8%)、白蛋白(5.5%)和石蜡酰(5.5%)。3.70%的病房采用固定的静脉注射联合疗法(主要是镇痛药与皮质类固醇或维生素)4。在几乎一半的单位中,存在恒定的TPN配方(46%)。只有少数被命名的组合被研究或测试了稳定性。大多数外加剂的相容性是未知的,而少数外加剂显然是不相容的。已知其中一种载体溶液(Solcoseryl)的外加剂曾引起严重的并发症。对于几种外加剂,在文献中发现了相互矛盾的相容性数据。讨论了不相容的理论基础,并给出了一些典型的例子。同时给出了外加剂的一些规则。关于同时肠外用药的相容性的问题太具体了,大多数医生无法回答。这方面的建议和辅导应成为临床药师的一项新任务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Effects of a defined infusion of 10% HAES 200/0.5 in the early phase of a septic syndrome on hemodynamic parameters]. [Tolerance of Haemofusin in hemodilution and volume substitution]. Posttraumatic hypocaloric parenteral nutrition--development and clinical application. [Are omega-3-fatty acids essential for newborn infants?]. [PEDINFUS computer program for total parenteral nutrition of children].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1